Cargando…

Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Cardiomyocyte loss following myocardial infarction cannot be addressed with current clinical therapies. Cell therapy with induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) is a potential approach to replace cardiomyocyte loss. However, engraftment rates in pre-clinical studies have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bui, Thuy Anh, Stafford, Nicholas, Oceandy, Delvac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487209/ https://www.ncbi.nlm.nih.gov/pubmed/37681853 http://dx.doi.org/10.3390/cells12172121

Ejemplares similares

Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival
por: Robertson, Abigail, et al.
Publicado: (2017)

Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU‐MP‐1, protects the heart against adverse effects during pressure overload
por: Triastuti, Efta, et al.
Publicado: (2019)

Advanced glycation end products reduce the calcium transient in cardiomyocytes by increasing production of reactive oxygen species and nitric oxide
por: Hegab, Zeinab, et al.
Publicado: (2017)

Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes
por: Yasutake, Hideki, et al.
Publicado: (2021)

Enhancement of the Therapeutic Capacity of Mesenchymal Stem Cells by Genetic Modification: A Systematic Review
por: Pawitan, Jeanne Adiwinata, et al.
Publicado: (2020)

Recent advances in regulating the proliferation or maturation of human-induced pluripotent stem cell-derived cardiomyocytes
por: Yang, Hao, et al.
Publicado: (2023)

Physiological and pharmacological stimulation for in vitro maturation of substrate metabolism in human induced pluripotent stem cell-derived cardiomyocytes
por: Lopez, Colleen A., et al.
Publicado: (2021)

Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
por: Rajamohan, Divya, et al.
Publicado: (2016)

Calcium Homeostasis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Lee, Yee-Ki, et al.
Publicado: (2011)

Calcium Handling in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
por: Itzhaki, Ilanit, et al.
Publicado: (2011)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
por: Hoekstra, Maaike, et al.
Publicado: (2012)

Cytotoxicity of propofol in human induced pluripotent stem cell-derived cardiomyocytes
por: Kido, Koji, et al.
Publicado: (2017)

Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
por: Machiraju, Pranav, et al.
Publicado: (2019)

Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes
por: Wu, Peng, et al.
Publicado: (2021)

Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains
por: Zi, Min, et al.
Publicado: (2019)

The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice
por: Omede, Ameh, et al.
Publicado: (2016)

Micro RNA-411 Expression Improves Cardiac Phenotype Following Myocardial Infarction in Mice
por: Nugroho, Ardiansah Bayu, et al.
Publicado: (2022)

Aconitine-induced cardiac arrhythmia in human induced pluripotent stem cell-derived cardiomyocytes
por: Zhang, Feng, et al.
Publicado: (2018)

Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Yuecel, Goekhan, et al.
Publicado: (2023)

Liensinine- and Neferine-Induced Cardiotoxicity in Primary Neonatal Rat Cardiomyocytes and Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Yu, Yangyang, et al.
Publicado: (2016)

Using human induced pluripotent stem cell-derived cardiomyocytes to understand the mechanisms driving cardiomyocyte maturation
por: Hamledari, Homa, et al.
Publicado: (2022)

Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-Cardiomyocytes
por: Maillet, Agnes, et al.
Publicado: (2016)

Excitation–contraction coupling of human induced pluripotent stem cell-derived cardiomyocytes
por: Kane, Christopher, et al.
Publicado: (2015)

Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes
por: Lei, Wei, et al.
Publicado: (2018)

Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies
por: Brodehl, Andreas, et al.
Publicado: (2019)

Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Huang, Mo-Fan, et al.
Publicado: (2021)

Cyclophosphamide arrhythmogenicitytesting using human-induced pluripotent stem cell-derived cardiomyocytes
por: Podgurskaya, A. D., et al.
Publicado: (2021)

Optical Mapping of Cardiomyocytes in Monolayer Derived from Induced Pluripotent Stem Cells
por: Djemai, Mohammed, et al.
Publicado: (2023)

The plasma membrane calcium ATPase 4 signalling in cardiac fibroblasts mediates cardiomyocyte hypertrophy
por: Mohamed, Tamer M. A., et al.
Publicado: (2016)

YAP Induces Human Naive Pluripotency
por: Qin, Han, et al.
Publicado: (2016)

Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
por: Chaudhari, Umesh, et al.
Publicado: (2017)

Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screening
por: Sharma, Arun, et al.
Publicado: (2013)

Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure
por: Gherghiceanu, Mihaela, et al.
Publicado: (2011)

Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation
por: Brodarac, Andreja, et al.
Publicado: (2015)

Clinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem Cells
por: Ng, Kwong-Man, et al.
Publicado: (2014)

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Zhao, Zhihan, et al.
Publicado: (2018)

Modelling cadmium‐induced cardiotoxicity using human pluripotent stem cell‐derived cardiomyocytes
por: Shen, Jiaxi, et al.
Publicado: (2018)

Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research
por: Mummery, Christine L.
Publicado: (2018)

Induced Pluripotent Stem Cell–Derived Cardiomyocytes Provide In Vivo Biological Pacemaker Function
por: Chauveau, Samuel, et al.
Publicado: (2017)

Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function
por: Wnorowski, Alexa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_admbaks8mjtj9lr51ji33pn773